Enhanced Activation and Expansion of T Cells Using Mechanically Soft Elastomer Fibers
Overview
Biomedical Engineering
Biotechnology
Authors
Affiliations
Practical deployment of cellular therapies requires effective platforms for producing clinically relevant numbers of high-quality cells. This report introduces a materials-based approach to improving activation and expansion of T cells, which are rapidly emerging as an agent for treating cancer and a range of other diseases. Electrospinning is used to create a mesh of poly(ε-caprolactone) fibers, which is used to present activating ligands to CD3 and CD28, which activate T cells for expansion. Incorporation of poly(dimethyl siloxane) elastomer into the fibers reduces substrate rigidity and enhances expansion of mixed populations of human CD4 and CD8 T cells. Intriguingly, this platform also rescues expansion of T cells isolated from CLL patients, which often show limited responsiveness and other features resembling exhaustion. By simplifying the process of cell expansion, compared to current bead-based platforms, and improving T cell expansion, the system introduced here may accelerate development of cellular immunotherapy.
Taming Variability in T-Cell Mechanosensing.
Schultheiss P, Pulkundwar A, Li W, Kam L Cells. 2025; 14(3).
PMID: 39936994 PMC: 11817355. DOI: 10.3390/cells14030203.
Assaying and classifying T cell function by cell morphology.
Wang X, Fernandes S, Brown J, Kam L BioMedInformatics. 2024; 4(2):1144-1154.
PMID: 39525274 PMC: 11542667. DOI: 10.3390/biomedinformatics4020063.
encapsulation and expansion of T and CAR-T cells using 3D synthetic thermo-responsive matrices.
Lizana-Vasquez G, Mendez-Vega J, Cappabianca D, Saha K, Torres-Lugo M RSC Adv. 2024; 14(20):13734-13747.
PMID: 38681842 PMC: 11046447. DOI: 10.1039/d4ra01968g.
Wang J, Yin Y, Ren X, Wang S, Zhu Y J Mater Sci Mater Med. 2024; 35(1):21.
PMID: 38526656 PMC: 10963565. DOI: 10.1007/s10856-024-06786-y.
Preclinical models for development of immune-oncology therapies.
Wang Y, Shelton S, Kastrunes G, Barbie D, Freeman G, Marasco W Immuno-oncol Insights. 2023; 3(8):379-398.
PMID: 37132013 PMC: 10150782. DOI: 10.18609/ioi.2022.41.